217 related articles for article (PubMed ID: 23737036)
1. Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: a population-based study.
Sleeman KE; Ho YK; Verne J; Glickman M; Silber E; Gao W; Higginson IJ;
Palliat Med; 2013 Oct; 27(9):840-6. PubMed ID: 23737036
[TBL] [Abstract][Full Text] [Related]
2. The Palliative Care Needs of Patients with Multiple Sclerosis, Parkinson's Related Diseases, and Motor Neurone Disease: A Secondary Analysis of the OPTCARE Neuro Trial Data.
Doherty M; Chukwusa E; McQuillan R; Cranfield F; Gao W
J Palliat Med; 2024 May; 27(5):622-629. PubMed ID: 38597932
[No Abstract] [Full Text] [Related]
3. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.
Goldacre MJ; Duncan M; Griffith M; Turner MR
J Neurol; 2010 May; 257(5):706-15. PubMed ID: 19946783
[TBL] [Abstract][Full Text] [Related]
4. Reversal of English trend towards hospital death in dementia: a population-based study of place of death and associated individual and regional factors, 2001-2010.
Sleeman KE; Ho YK; Verne J; Gao W; Higginson IJ;
BMC Neurol; 2014 Mar; 14():59. PubMed ID: 24666928
[TBL] [Abstract][Full Text] [Related]
5. Changing patterns in place of cancer death in England: a population-based study.
Gao W; Ho YK; Verne J; Glickman M; Higginson IJ;
PLoS Med; 2013; 10(3):e1001410. PubMed ID: 23555201
[TBL] [Abstract][Full Text] [Related]
6. Birthplace as a risk factor in motor neurone disease and Parkinson's disease.
Betemps EJ; Buncher CR
Int J Epidemiol; 1993 Oct; 22(5):898-904. PubMed ID: 8282470
[TBL] [Abstract][Full Text] [Related]
7. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
Elian M; Dean G
Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
[TBL] [Abstract][Full Text] [Related]
8. Place of death in Parkinson's disease and related disorders in England and Wales: post-pandemic trends and implications for care planning.
Wilson E; Baker A; Stockley L; Allgar V; Richfield E
Age Ageing; 2024 Mar; 53(3):. PubMed ID: 38497239
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses.
Li TM; Swash M; Alberman E
J Neurol Neurosurg Psychiatry; 1985 Apr; 48(4):320-7. PubMed ID: 3873517
[TBL] [Abstract][Full Text] [Related]
10. Place of death in children and young people with cancer and implications for end of life care: a population-based study in England, 1993-2014.
Gao W; Verne J; Peacock J; Stiller C; Wells C; Greenough A; Higginson IJ
BMC Cancer; 2016 Sep; 16(1):727. PubMed ID: 27641492
[TBL] [Abstract][Full Text] [Related]
11. Caregiver support and place of death among older adults.
Lei L; Gerlach LB; Powell VD; Maust DT
J Am Geriatr Soc; 2021 May; 69(5):1221-1230. PubMed ID: 33590479
[TBL] [Abstract][Full Text] [Related]
12. The place of death in Parkinson's disease.
Snell K; Pennington S; Lee M; Walker R
Age Ageing; 2009 Sep; 38(5):617-9. PubMed ID: 19628680
[No Abstract] [Full Text] [Related]
13. Reversal of the British trends in place of death: time series analysis 2004-2010.
Gomes B; Calanzani N; Higginson IJ
Palliat Med; 2012 Mar; 26(2):102-7. PubMed ID: 22258367
[TBL] [Abstract][Full Text] [Related]
14. Place of death of people living with Parkinson's disease: a population-level study in 11 countries.
Moens K; Houttekier D; Van den Block L; Harding R; Morin L; Marchetti S; Csikos A; Loucka M; Naylor WA; Wilson DM; Teno J; Cardenas-Turanzas M; Rhee Y; Garcia-Leon FJ; Deliens L; Cohen J
BMC Palliat Care; 2015 May; 14():28. PubMed ID: 25990567
[TBL] [Abstract][Full Text] [Related]
15. Trends and Factors Associated with Place of Death for Individuals with Dementia in the United States.
Cross SH; Kaufman BG; Taylor DH; Kamal AH; Warraich HJ
J Am Geriatr Soc; 2020 Feb; 68(2):250-255. PubMed ID: 31609481
[TBL] [Abstract][Full Text] [Related]
16. Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data.
Cohen J; Beernaert K; Van den Block L; Morin L; Hunt K; Miccinesi G; Cardenas-Turanzas M; Onwuteaka-Philipsen B; MacLeod R; Ruiz-Ramos M; Wilson DM; Loucka M; Csikos A; Rhee YJ; Teno J; Ko W; Deliens L; Houttekier D
NPJ Prim Care Respir Med; 2017 Mar; 27(1):14. PubMed ID: 28258277
[TBL] [Abstract][Full Text] [Related]
17. Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.
Mylne AQ; Griffiths C; Rooney C; Doyle P
Eur J Neurol; 2009 Sep; 16(9):1010-6. PubMed ID: 19538202
[TBL] [Abstract][Full Text] [Related]
18. An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.
Steventon GB; Waring RH; Williams AC
Drug Metabol Drug Interact; 2003; 19(4):223-40. PubMed ID: 14768972
[TBL] [Abstract][Full Text] [Related]
19. Trends in place of death: The role of demographic and epidemiological shifts in end-of-life care policy.
Kalseth J; Theisen OM
Palliat Med; 2017 Dec; 31(10):964-974. PubMed ID: 28190375
[TBL] [Abstract][Full Text] [Related]
20. Regional variations in geographic access to inpatient hospices and Place of death: A Population-based study in England, UK.
Chukwusa E; Yu P; Verne J; Taylor R; Higginson IJ; Wei G
PLoS One; 2020; 15(4):e0231666. PubMed ID: 32302344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
